| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/02/2005 | CN1187057C Trivalent cerium carried rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof |
| 02/02/2005 | CN1187045C Substances for use in treating psoriasis |
| 02/02/2005 | CN1187036C Personal cleaning compositions comprising mid-chain branched surfactants |
| 02/02/2005 | CN1187035C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849718 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 02/01/2005 | US6849663 Particularly septic shock |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 02/01/2005 | US6849637 Matrix metalloproteases (MMPs) inhibitors such as benzyl 4-benzyl-5-oxo-4H-(1,2,4)triazolo(4,3-a)quinazol-7-ylcarboxylate for inflammatory conditions such as rheumatoid arthritis or osteoarthritis, or cancer |
| 02/01/2005 | US6849631 Semicarbazides and their uses |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849260 Methods and compositions for treating IgE-related disease using NNT-1 inhibitors |
| 02/01/2005 | CA2362698C Resorcinol derivatives |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007699A2 Human antibody molecules for il-13 |
| 01/27/2005 | WO2005007646A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | WO2005007616A1 Diphenylamino ketone derivatives as mek inhibitors |
| 01/27/2005 | WO2005007184A2 Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |
| 01/27/2005 | WO2005007163A1 Antipruritic agent containing chroman compound as active ingredient |
| 01/27/2005 | WO2005007161A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 01/27/2005 | WO2005007151A1 Chromatosis remedies |
| 01/27/2005 | WO2005007125A1 Preparation for topical use with the function of combating hair loss |
| 01/27/2005 | WO2004092118A3 2-propylidene-19-nor-vitamin d compounds |
| 01/27/2005 | US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 01/27/2005 | US20050020832 For therapy of atherosclerosis |
| 01/27/2005 | US20050020691 Pharmaceutical preparations comprising substituted beta-aminoalcohols |
| 01/27/2005 | US20050020656 L-histidine, D-histidine, DL-histidine, and/or salts thereof, and optionally cysteine, and/or cystine or salts; fibrosis may be of the kidney, pancreas, lung, vascular vessels, skin, bone marrow, or liver; may be given in foods or beverages |
| 01/27/2005 | US20050020624 Dihydroindole and tetrahydroquinoline derivatives |
| 01/27/2005 | US20050020583 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | US20050020199 Coin guiding apparatus |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| 01/27/2005 | US20050019426 Use of an aqueous or hydroalcoholic extract from bauhinia for the preparation of a composition |
| 01/27/2005 | US20050019425 Animal feeds contains selenium, for promoting hair growth |
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019383 Adhesive surface with indentations; second component being separated by a cup shaped metal foil barrier layer with a rim extending into a flange; wound healing agents; topical |
| 01/27/2005 | US20050019378 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 01/27/2005 | US20050019310 Method for culturing and expansion of mammalian undifferentiated epidermal kerainocytes exhibiting stem cell characteristics |
| 01/27/2005 | US20050019301 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition |
| 01/27/2005 | US20050019297 Protein derived composition for skin care using spider silk protein or an analog with adjuvants |
| 01/27/2005 | US20050019289 Hair repairing liquid comprising water dispersed with ultrafine particle titanium group metal by plasma underwater discharge and method and system for producing the same |
| 01/27/2005 | CA2805464A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2804901A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2532313A1 Medicament for treatment of dermal pigmentation |
| 01/27/2005 | CA2531401A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | CA2529777A1 Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |
| 01/26/2005 | EP1500652A1 Quinazoline derivative and medicine |
| 01/26/2005 | EP1499746A1 Method to inhibit cell growth using oligonucleotides |
| 01/26/2005 | EP1499719A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
| 01/26/2005 | EP1499631A2 Rna interference mediated inhibition of tgf-beta and tgf-beta receptor gene expression using short interfering nucleic acid (sina) |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499613A1 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 01/26/2005 | EP1499605A2 NF-KappaB INHIBITORS |
| 01/26/2005 | EP1499604A1 Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentaidenoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 01/26/2005 | EP1499601A1 New 2-substituted -1,3-thiazole compounds |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499585A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 01/26/2005 | EP1499578A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499330A1 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 01/26/2005 | EP1499325A1 Methods and compositions for inhibition of irritation by disaccharide and metal ions |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499312A1 The use of hydroxypyridone-derivatives in wound healing |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | EP1499294A2 Transport system in biological systems |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1233748B1 Retinaldehyde combination with antifungal activity |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/26/2005 | EP0706370B2 Use of non-ionic surfactants in stable topical retinoid compositions |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571835A Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571782A Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571673A Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 01/26/2005 | CN1571660A Solid pharmaceutical agent formulation for a piperazine urea derivative |
| 01/26/2005 | CN1569896A Preparation of composite specific yelk antibody igy against cutaneous infection and its use in treatment of cutaneous infection |
| 01/26/2005 | CN1569220A Application of gene recombined anti fungus peptide in the treatment of eumycetes infection |